[Other] Deucravacitinib in Psoriasis: Evidence, Gaps, and Place in Therapy |
|
This post will be closed automatically in 2026-08-19 00:08
Reward20points
|
20
Incidence of safety events after immune checkpoint inhibitor initiation for advanced-stage non-small-cell lung cancer: a real-world study
20
Semiparametric Inference for Longitudinal Data with Informative Observation Times and Terminal Event
20
The Impact of Structural Barriers on Black Men＊s Health-Seeking Behaviours in the Public Primary Healthcare Settings of Ga-Rankuwa Township, Pretoria, South Africa
20
Cure for psoriasis - a prospective outlook
50
[Full book]Controlling
